Funding to go towards better treatment of Cerebral Palsy, Epilepsy, and Neurodevelopmental Disorders
The Ontario Brian Institute has received a five-year commitment from the Province of Ontario to encourage, reward, and catalyze stronger collaboration and new ways of thinking around some of the most pervasive brain disorders of our time.
“Through early engagement of industry, commercialization of the research outcomes becomes a priority as opposed to an afterthought. By engaging clinicians and patient advocacy groups, patient needs are placed at the centre of cutting-edge research in an effort to improve their care. Science has learned that inspiration is a function of collaboration and that new answers come from both new perspectives and new people at the table,” says Dr. Donald Stuss, president and scientific director of the Ontario Brain Institute.
The three renewed programs are:
- POND Network – The Province of Ontario Neurodevelopmental Disorders Integrated Discovery Program — $18.75 million over 5 years
- CP-NET – The Cerebral Palsy Network Integrated Discovery Program — $7.5 million over 5 years
- EpLink – The Epilepsy Integrated Discovery Program — $11.25 million over 5 years
“We are learning through the POND Network that many of the genetic and brain changes in autism, ADHD, OCD and intellectual disability are shared between the disorders. Support from OBI puts us in a unique position to look at these disorders from the perspective of a continuum, and develop therapies unique to the individual,” says Dr. Evdokia Anagnostou, program lead for the POND Network.
“CP-NET is focused on improving the lives of individuals with cerebral palsy and their families by connecting them to a network of world-renowned researchers across Ontario. The ongoing support of OBI allows us to expand our network and broaden our impact for those living with cerebral palsy through new lines of research inquiry and innovative treatments,” comments Dr. Darcy Fehlings, program lead for CP-NET.
“The EpLink program is allowing us to do the work necessary to answer questions about epilepsy that we encounter in clinical practice, or questions from patients which we currently cannot answer. The continuation of EpLink through OBI facilitates research into these areas and will position Ontario as a world leader in epilepsy research and care,” adds Dr. Jorge Burneo, program co-lead for EpLink.
The OBI works with institutions to fund platforms for discovery where OBI contributes 2/3, and its hospital and university partners contribute the remaining 1/3 of the total program costs.
Details on the three programs may be found at: http://www.braininstitute.ca/research.